Showing 41 - 60 results of 269 for search '"chemotherapy"', query time: 0.08s Refine Results
  1. 41
  2. 42
  3. 43

    Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting by Erik Olsson, Henrik Lindman, Evangelos Digkas, Viktoria Thurfjell, Haidar Mir Ali, Ute Krüger, Anna-Karin Wennstig, Marie Sundqvist, Antonios Valachis

    Published 2025-02-01
    “…Altered genes and pathways were correlated with overall survival (OS) and evaluated regarding their association with real-world progression-free survival (rwPFS) in patients treated with different chemotherapy agents. Occurrence of alterations were compared between patients with exceptional response and rapid progression to chemotherapy. …”
    Get full text
    Article
  4. 44
  5. 45

    Breast Cancer: Epidemiology, Risk Factors and Survival Analysis in the Pakistani Population by Shumaila Zaib, Nosheen Masood, Jahangeer Sarwar Khan, Iqra, Azra Yasmin

    Published 2024-01-01
    Subjects: “…Breast cancer, nulliparous, chemotherapy, radiotherapy, surgery.…”
    Get full text
    Article
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50

    The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis by Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang

    Published 2021-06-01
    “…The outcomes were defined as incidence of FN in the first cycle and among all cycles of chemotherapy using three different definitions for FN. …”
    Get full text
    Article
  11. 51
  12. 52
  13. 53

    Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial by Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, Yong-Ming Chen, Yuan-Fang Li, Cheng-Cai Liang, Mu-Yan Cai, Guo-Ming Chen, Wei Wang, Xiao-Wei Sun, De-Sheng Weng, Dan-Dan Li, Jing-Jing Zhao, Xiao-Jiang Chen, Yuan-Xiang Guan, Zhi-Min Liu, Yao Liang, Ma Luo, Jun Chi, Hai-Bo Qiu, Zhi-Wei Zhou, Xiao-Shi Zhang, Ying-Bo Chen

    Published 2025-02-01
    “…Abstract This prospective, nonrandomized, open-label phase 2 trial (Chinese Clinical Trial Registry, ChiCTR2200061906) aimed to evaluate the effectiveness of adding the PD-1 antibody tislelizumab to perioperative chemotherapy in patients with locally advanced gastroesophageal junction adenocarcinoma (GEJA). …”
    Get full text
    Article
  14. 54

    Goodman and Gilman's the Pharmacological Basis of Therapeutics /

    Published 1980
    Subjects:
    View in OPAC
    Book
  15. 55
  16. 56
  17. 57
  18. 58

    Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemotherapy by November McGarvey, Hairong Xu

    Published 2015-11-01
    “…**Background:** Anemia is a common complication among patients with cancer receiving chemotherapy and can cause significant costs to health plans. …”
    Get full text
    Article
  19. 59
  20. 60